Oct 9, 2024, 16:50
Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile
Ghassan Abou-Alfa, Medical Oncologist, Memorial Sloan Kettering Cancer Center, shared a post on X:
“Congratulations and thank you Sebastian Mondaca on superb valuable effort for Chile. Memorial Sloan Kettering Cancer Center, MSK Department of Medicine, Ghassan Abou-Alfa and team are proud for contributing to ERBB2-altered gallbladder cancer characterization in Chile!”
Clinical and genomic characterization of ERBB2-altered gallbladder cancer
Authors: Sebastian Mondaca, Nikolaus Schultz, Juan Carlos Roa, Henry S. Walch, Santiago Sepulveda, James J. Harding, Amin Yaqubie, Patricia Garcia, Gloria Aguayo, Bruno Nervi, Bob T. Li and Ghassan K. Abou-Alfa.
Amin Yaqubie
Bob T. Li
Bruno Nervi
cancer
cancer awareness
cancer care
fight against cancer
Ghassan Abou-Alfa
Ghassan K. Abou-Alfa
Global fight against cancer
Gloria Aguayo
Henry S. Walch
James J. Harding
JCO
Journal of Clinical Oncology
Juan Carlos Roa
Memorial Sloan Kettering Cancer Center
MSK Department of Medicine
Nikolaus Schultz
OncoDaily
Oncology
Patricia Garcia
Santiago Sepulveda
Sebastian Mondaca
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 1, 2024, 19:12
Nov 1, 2024, 17:46
Nov 1, 2024, 17:41
Nov 1, 2024, 17:27